Literature DB >> 15454869

[Contribution of corticosteroid to the treatment of pain in the acute phase of Guillain-Barré syndrome].

R Kabore1, L Magy, S Boukhris, T Mabrouk, M Lacoste, J-M Vallat.   

Abstract

INTRODUCTION: Pain is a common problem in both adults and children with Guillain-Barré Syndrome (GBS). Corticosteroids are rarely used in the treatment of pain in the course of GBS, although some authors have pointed out their value for the treatment of neuropathic pain. We report four patients with GBS whose pain was rapidly relieved by administration of corticosteroids.
METHODS: We reviewed retrospectively a series of four patients with GBS seen from September 2001 to February 2003. All patients had plexual (Case 3), trunkular (case 1), radicular (case 2) or focal (case 4) pain. Pain was treated with corticosteroids via oral (cases 1 and 2) or intravenous routes (cases 3 and 4). Corticoids where used after failure of other analgesic agents.
RESULTS: Pain relief was obtained after the first administration and persisted even after tapering off steroid treatment. No particular complication was observed during treatment course.
CONCLUSION: Our experience suggests that controlled studies should be set up to evaluate the place of corticosteroid treatment for the management of pain in patients with GBS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454869     DOI: 10.1016/s0035-3787(04)71037-1

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  5 in total

1.  [Guillain-Barré syndrome in hospitals in Togo].

Authors:  K Apetse; J J Dongmo Tajeuna; V K Kumako; K P Waklatsi; D Kombate; K Assogba; A K Balogou
Journal:  Med Trop Sante Int       Date:  2021-09-04

Review 2.  Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.

Authors:  José Berciano; María J Sedano; Ana L Pelayo-Negro; Antonio García; Pedro Orizaola; Elena Gallardo; Miguel Lafarga; María T Berciano; Bart C Jacobs
Journal:  J Neurol       Date:  2016-06-17       Impact factor: 4.849

Review 3.  Use of natural compounds in the management of diabetic peripheral neuropathy.

Authors:  Maria Galuppo; Sabrina Giacoppo; Placido Bramanti; Emanuela Mazzon
Journal:  Molecules       Date:  2014-03-05       Impact factor: 4.411

4.  Guillain-Barré Syndrome with Rapid Onset and Autonomic Dysfunction Following First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report.

Authors:  Tyler Ashford Lanman; Connie Wu; Helen Cheung; Neelam Goyal; Maxwell Greene
Journal:  Neurohospitalist       Date:  2022-04

5.  Determination of pain and response to methylprednisolone in Guillain-Barré syndrome.

Authors:  Liselotte Ruts; Rinske van Koningsveld; Bart C Jacobs; Pieter A van Doorn
Journal:  J Neurol       Date:  2007-04-11       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.